Squire is the Founder & Managing Partner of Syridex Bio. Prior to founding Syridex Bio, he served as SVP, General Counsel & Corporate Secretary at Repligen Corporation, a bioprocessing-focused life sciences company. At Repligen, Squire led the legal, corporate secretary, compliance and enterprise risk functions as well as counseled the company’s Board of Directors and senior management. He also served on Repligen’s environmental, social, and corporate governance committee. Squire joined Repligen from Baxter International, Inc. where he led the global legal team supporting their multi-billion-dollar global pharmaceuticals business. Prior to joining Baxter, Squire worked in a variety of settings including as a Director providing legal support to Dr. Reddy’s Laboratories business development team and as a life sciences attorney with Morgan, Lewis & Bockius LLP.
Squire received his J.D. from Duke University School of Law and M.B.A. with a concentration in corporate finance and a Certificate in Health Sector Management from Duke University, Fuqua School of Business. He received his B.S., with honors, with a double major in biomedical engineering and cell biology and neuroscience from Rutgers University, School of Engineering.